Gilead Rallies Off Epclusa Approval

By: via Benzinga
Gilead Sciences, Inc. (NASDAQ: GILD) shares are trading higher by $2.63 at $80.88 in Tuesday's session. The catalyst for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.